It is estimated that with the availability of synthetic interferons this may reduce to a cost of one dollar per day. A number of other proteins like urokinase, factor VII: C, human growth hormone (HGH) and many other drugs will soon be available through this technique.
In 1985, human growth hormone for treating hypopitiuitary dwarfism was synthesized using recombinant DNA technique and was approved for commercial marketing under the name prototropin in USA and under the name somatonorm in Britain. Both insulin (manufactured by Eli Lilley) and this growth hormone were manufactured under licence from Genentech Inc. based in USA.



